Live Breaking News & Updates on Diagnostics Sector Stocks
Stay updated with breaking news from Diagnostics sector stocks. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
In the last four years, many sectors have made a comeback. However, there are few, who have probably a full life cycle in this short period of time. From all the love on the street which made them touch dizzy heights of valuations. Then a realization that the street is paying too much for them. It is about the diagnostic sector. From being part of a star portfolio manager tops picks, to him admitting that he made a mistake. Diagnostic stocks have seen a cycle. There is another side to the story. Every sector which goes through such cycles in the short term, tends to see a recovery. The only difference is the recovery time, both of the business and getting recognised once again by the street. So, these stocks will make a comeback, whether it happens in one quarter or after years is the question. But one thing is for sure, that if you are a long term investor, don t be in a hurry to get out of the sector. ....
There are some businesses whose underlying nature is such that they don t have any sudden spike in their profits. However at the same time, there is constant growth. The growth could be because of many reasons, it may be because of the fact that penetration of that good or service is very low and over a period of time as it improves, both top and bottom line keep moving upward. In some cases, it could be because of the movement of business from the unorganized sector to the organized sector. It could also be because of the fact that the need is such that if required spending on it cannot be postponed. In the case of diagnostic business, it is all the three. But there is another side to it, how the street is treating these businesses when it comes to valuations. In case of diagnostics, from dizzy heights of valuation in 2021 to today where it is being seen as a sector where there is nothing worth looking at this point of time due to multiple issues. Yes, there are real issues with the b ....
In the last five years, the diagnostic segment of the healthcare sector has seen many ups and downs. During Covid, diagnostic players were overloaded with work and then came the price wars which some new tech companies brought on the table. The price war was essentially started to grab both, market and mind share. While the price war is still on in some segments, there is a possibility that its intensity may come down. The reason, new companies have burnt enough cash and large physical-only players have also made some inroads into digital channels for customer acquisition and also part delivery of the service. Will this bring back focus of the street? ....